Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication
JACC: Cardiovascular Interventions · 2024
DOI: 10.1016/j.jcin.2024.04.012 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2024. Verfasst von Errol W Aarnink und 47 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Sint Antonius Ziekenhuis, Nieuwegein, the Netherlands; Department of Cardiology, Amsterdam University Medical Center, Amste…. Hauptthemen laut MEDLINE: Atrial Appendage, Atrial Fibrillation, Anticoagulants, Contraindications, Drug. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Left atrial appendage occlusion (LAAO) provides mechanical cardioembolic protection for atrial fibrillation (AF) patients who cannot use oral anticoagulation therapy (OAT). Patients with a thrombotic event despite OAT are at high risk for recurrence and may also benefit from LAAO. OBJECTIVES: This study sought to investigate the efficacy of LAAO in AF patients with a thrombotic event on OAT compared to: 1) LAAO in AF patients with a contraindication for OAT; and 2) historical data. METHODS: The international LAAO after stroke despite oral anticoagulation (STR-OAC LAAO) collaboration included patients who underwent LAAO because of thrombotic events on OAT. This cohort underwent propensity score matching and was compared to the EWOLUTION (Evaluating Real-Life Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology) registry, which represents patients who underwent LAAO because of OAT contraindications. The primary outcome was ischemic stroke. Event rates were compared between cohorts and with historical data without OAT, yielding relative risk reductions based on risk scores. RESULTS: Analysis of 438 matched pairs revealed no significant difference in the ischemic stroke rate between the STR-OAC LAAO and EWOLUTION cohorts (2.5% vs 1.9%; HR: 1.37; 95% CI: 0.72-2.61). STR-OAC LAAO patients exhibited a higher thromboembolic risk (HR: 1.71; 95% CI: 1.04-2.83) but lower bleeding risk (HR: 0.39; 95% CI: 0.18-0.88) compared to EWOLUTION patients. The mortality rate was slightly higher in EWOLUTION (4.3% vs 6.9%; log-rank P = 0.028). Relative risk reductions for ischemic stroke were 70% and 78% in STR-OAC LAAO and EWOLUTION, respectively, compared to historical data without OAT. CONCLUSIONS: LAAO in patients with a thrombotic event on OAT demonstrated comparable stroke rates to the OAT contraindicated population in EWOLUTION. The thromboembolic event rate was higher and the bleeding rate lower, reflecting the intrinsically different risk profile of both populations. Until randomized trials are available, LAAO may be considered in patients with an ischemic event on OAT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Sint Antonius Ziekenhuis, Nieuwegein, the Netherlands; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, the Netherlands. Electronic address: e.aarnink@antoniusziekenhui…
- Department of Cardiology, Sint Antonius Ziekenhuis, Nieuwegein, the Netherlands; Department of Cardiology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
- De Gasperis Cardio Center, Interventional Cardiology Unit, Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Arrhythmia Unit and Electrophysiology Laboratories, Azienda Socio-Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- IRCCS, San Raffaele Scientific Institute, Milan, Italy.
- Department of Clinical Electrophysiology and Cardiac Pacing, Centro Cardiologico Monzino, Instituti di Ricovero e Cura a Carattere Scientifico, Milan, Italy; Department of Biomedical, Surgical and Dental Sciences, Unive…
Zitieren
APA
Aarnink, E. W., Maarse, M., Fierro, N., Mazzone, P., Beneduce, A., Tondo, C., Gasperetti, A., Pracon, R., Demkow, M., Zieliński, K., de Backer, O., Korsholm, K., Nielsen-Kudsk, J. E., Estévez-Loureiro, R., Caneiro-Queija, B., Benito-González, T., Pérez de Prado, A., Nombela-Franco, L., Salinas, P., …, & STR-OAC LAAO and EWOLUTION Investigators (2024). Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2024.04.012
Vancouver
Aarnink EW, Maarse M, Fierro N, Mazzone P, Beneduce A, Tondo C, et al. Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication. JACC: Cardiovascular Interventions. 2024. doi:10.1016/j.jcin.2024.04.012
BibTeX
@article{Aarnink2024,
author = {Aarnink, Errol W and Maarse, Moniek and Fierro, Nicolai and Mazzone, Patrizio and Beneduce, Alessandro and Tondo, Claudio and Gasperetti, Alessio and Pracon, Radoslaw and Demkow, Marcin and Zieliński, Kamil and de Backer, Ole and Korsholm, Kasper and Nielsen-Kudsk, Jens Erik and Estévez-Loureiro, Rodrigo and Caneiro-Queija, Berenice and Benito-González, Tomás and Pérez de Prado, Armando and Nombela-Franco, Luis and Salinas, Pablo and Holmes, David and Almakadma, Abdul H and Berti, Sergio and Romeo, Maria Rita and Millan, Xavier and Arzamendi, Dabit and Alla, Venkata M and Agarwal, Himanshu and Eitel, Ingo and Paitazoglou, Christina and Freixa, Xavier and Cepas-Guillén, Pedro and Chothia, Rashaad and Badejoko, Solomon O and Spoon, Daniel B and Maddux, James T and El-Chami, Mikhael and Ram, Pradhum and Branca, Luca and Adamo, Marianna and Suradi, Hussam S and Peper, Joyce and van Dijk, Vincent F and Rensing, Benno J W M and Swaans, Martin J and Vireca, Elisa and Bergmann, Martin W and Boersma, Lucas V A and STR-OAC LAAO and EWOLUTION Investigators, STR-OAC LAAO and EWOLUTION Investigators},
title = {Left Atrial Appendage Occlusion in Patients With Anticoagulation Failure vs Anticoagulation Contraindication},
journal = {JACC: Cardiovascular Interventions},
year = {2024},
doi = {10.1016/j.jcin.2024.04.012}
}
EUVIMED